NYSEMKT: NNVC
Nanoviricides Inc Stock Ownership - Who owns Nanoviricides?

Insider buying vs selling

Have Nanoviricides Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when NNVC insiders and whales buy or sell their stock.

NNVC Shareholders

What type of owners hold Nanoviricides Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Theracour Pharma Inc191.16%33,321,000$45.65MInsider
Milton Boniuk85.06%14,827,438$20.31MInsider
Anil Diwan11.73%2,044,918$2.80MInsider
Eugene Seymour7.16%1,248,814$1.71MInsider
Vanguard Group Inc2.93%510,416$699.27kInstitution
Stephenson Fournier PLLC2.82%491,721$673.66kInsider
Meeta Vyas2.52%439,570$602.21kInsider
Blackrock Inc0.91%158,752$217.49kInstitution
Geode Capital Management LLC0.91%157,994$216.45kInstitution
Ubs Group Ag0.67%117,168$160.52kInstitution

1 of 3

NNVC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NNVC2.49%97.51%
PPCB0.00%0.00%
MTVA0.81%99.19%Net Buying
PMN16.36%49.85%Net BuyingNet Buying
LPTX28.54%71.46%Net Selling

Nanoviricides Stock Ownership FAQ

Who owns Nanoviricides?

Nanoviricides (NYSEMKT: NNVC) is owned by 7.66% institutional shareholders, 300.46% Nanoviricides insiders, and 0.00% retail investors. Theracour Pharma Inc is the largest individual Nanoviricides shareholder, owning 33.32M shares representing 191.16% of the company. Theracour Pharma Inc's Nanoviricides shares are currently valued at $45.32M.

If you're new to stock investing, here's how to buy Nanoviricides stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.